123 related articles for article (PubMed ID: 37832390)
21. Discovery and Validation of Hypermethylated Markers for Colorectal Cancer.
Wei J; Li G; Dang S; Zhou Y; Zeng K; Liu M
Dis Markers; 2016; 2016():2192853. PubMed ID: 27493446
[TBL] [Abstract][Full Text] [Related]
22. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
[TBL] [Abstract][Full Text] [Related]
23. Quantitative assessment of AKAP12 promoter methylation in colorectal cancer using methylation-sensitive high resolution melting: Correlation with Duke's stage.
Liu W; Guan M; Su B; Ye C; Li J; Zhang X; Liu C; Li M; Lin Y; Lu Y
Cancer Biol Ther; 2010 Jun; 9(11):862-71. PubMed ID: 20364105
[TBL] [Abstract][Full Text] [Related]
24. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population.
Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP
Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022
[TBL] [Abstract][Full Text] [Related]
25. Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy.
Jin S; Zhu D; Shao F; Chen S; Guo Y; Li K; Wang Y; Ding R; Gao L; Ma W; Lu T; Li D; Zhang Z; Cai S; Liang X; Song H; Ji L; Li J; Zheng Z; Jiang F; Wu X; Luan J; Zhang H; Yang Z; Cantor CR; Xu C; Ding C
Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495330
[TBL] [Abstract][Full Text] [Related]
26. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation.
Wojdacz TK; Dobrovic A
Nucleic Acids Res; 2007; 35(6):e41. PubMed ID: 17289753
[TBL] [Abstract][Full Text] [Related]
27. Methylation-sensitive high-resolution melting.
Wojdacz TK; Dobrovic A; Hansen LL
Nat Protoc; 2008; 3(12):1903-8. PubMed ID: 19180074
[TBL] [Abstract][Full Text] [Related]
28. Potential of quantitative SEPT9 and SHOX2 methylation in plasmatic circulating cell-free DNA as auxiliary staging parameter in colorectal cancer: a prospective observational cohort study.
Bergheim J; Semaan A; Gevensleben H; Groening S; Knoblich A; Dietrich J; Weber J; Kalff JC; Bootz F; Kristiansen G; Dietrich D
Br J Cancer; 2018 May; 118(9):1217-1228. PubMed ID: 29610456
[TBL] [Abstract][Full Text] [Related]
29. Identification of novel DNA methylation markers in colorectal cancer using MIRA-based microarrays.
Li H; Du Y; Zhang D; Wang LN; Yang C; Liu B; Wang WJ; Shi L; Hong WG; Zhang L; Yang YX
Oncol Rep; 2012 Jul; 28(1):99-104. PubMed ID: 22552777
[TBL] [Abstract][Full Text] [Related]
30. Rapid determination of AKAP12 promoter methylation levels in peripheral blood using methylation-sensitive high resolution melting (MS-HRM) analysis: application in colorectal cancer.
Liu W; Guan M; Su B; Li J; Ma W; Liu C; Li M; Lin Y; Lu Y
Clin Chim Acta; 2010 Jul; 411(13-14):940-6. PubMed ID: 20227403
[TBL] [Abstract][Full Text] [Related]
31. Early detection of the major male cancer types in blood-based liquid biopsies using a DNA methylation panel.
Constâncio V; Nunes SP; Moreira-Barbosa C; Freitas R; Oliveira J; Pousa I; Oliveira J; Soares M; Dias CG; Dias T; Antunes L; Henrique R; Jerónimo C
Clin Epigenetics; 2019 Dec; 11(1):175. PubMed ID: 31791387
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous Analysis of SEPT9 Promoter Methylation Status, Micronuclei Frequency, and Folate-Related Gene Polymorphisms: The Potential for a Novel Blood-Based Colorectal Cancer Biomarker.
Ravegnini G; Zolezzi Moraga JM; Maffei F; Musti M; Zenesini C; Simeon V; Sammarini G; Festi D; Hrelia P; Angelini S
Int J Mol Sci; 2015 Dec; 16(12):28486-97. PubMed ID: 26633373
[TBL] [Abstract][Full Text] [Related]
33. Novel Assay for Quantitative Analysis of DNA Methylation at Single-Base Resolution.
Yu H; Bai L; Tang G; Wang X; Huang M; Cao G; Wang J; Luo Y
Clin Chem; 2019 May; 65(5):664-673. PubMed ID: 30737203
[TBL] [Abstract][Full Text] [Related]
34. [One-step methylation variable position analysis technology in single-tube].
Yue YY; Zhao GS; Zhang Q; Lu D; Zhai XD; Mo YN
Fa Yi Xue Za Zhi; 2013 Dec; 29(6):419-24. PubMed ID: 24665611
[TBL] [Abstract][Full Text] [Related]
35. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer.
deVos T; Tetzner R; Model F; Weiss G; Schuster M; Distler J; Steiger KV; Grützmann R; Pilarsky C; Habermann JK; Fleshner PR; Oubre BM; Day R; Sledziewski AZ; Lofton-Day C
Clin Chem; 2009 Jul; 55(7):1337-46. PubMed ID: 19406918
[TBL] [Abstract][Full Text] [Related]
36. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
37. [Scanning for KRAS, NRAS, BRAF, and PIK3CA mutations by DNA melting analysis with TaqMan probes].
Botezatu IV; Panchuk IO; Stroganova AM; Senderovich AI; Kondratova VN; Shelepov VP; Lichtenstein AV
Mol Biol (Mosk); 2017; 51(1):50-58. PubMed ID: 28251966
[TBL] [Abstract][Full Text] [Related]
38. Multiplex fluorescence melting curve analysis for mutation detection with dual-labeled, self-quenched probes.
Huang Q; Liu Z; Liao Y; Chen X; Zhang Y; Li Q
PLoS One; 2011 Apr; 6(4):e19206. PubMed ID: 21552536
[TBL] [Abstract][Full Text] [Related]
39. Aberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patients.
Takane K; Midorikawa Y; Yagi K; Sakai A; Aburatani H; Takayama T; Kaneda A
Cancer Med; 2014 Oct; 3(5):1235-45. PubMed ID: 24861485
[TBL] [Abstract][Full Text] [Related]
40. Highly sensitive detection of DNA hypermethylation in melanoma cancer cells.
Nesvet J; Rizzi G; Wang SX
Biosens Bioelectron; 2019 Jan; 124-125():136-142. PubMed ID: 30366258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]